Recall report: Acella pulls thyroid tablets after a raft of side effect reports; mislabeling causes Pfizer's Hospira to yank 2 lots of anesthetics
Acella Pharmaceuticals has pulled its NP Thyroid tablets off US shelves after routine testing found different versions of the drug not hitting potency marks. In …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.